Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -195,645 | -124,096 | -51,527 | -246,290 | -190,361 |
| Depreciation Amortization | 1,871 | 1,213 | 578 | 2,188 | 1,369 |
| Accounts receivable | -15,896 | -2,079 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,055 | 8,982 | 5,914 | 1,921 | 2,198 |
| Other Working Capital | -10,208 | 3,492 | 1,764 | 12,362 | 2,463 |
| Other Operating Activity | 43,076 | -671 | -11,878 | 61,090 | 67,296 |
| Operating Cash Flow | $-171,747 | $-113,159 | $-55,149 | $-168,729 | $-117,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,010 | -1,605 | -657 | -801 | -627 |
| Purchase Sale Intangibles | -2,833 | -1,900 | N/A | -2,008 | -1,408 |
| Other Investing Activity | -2,833 | -1,900 | 0 | -2,027 | -1,408 |
| Investing Cash Flow | $-5,843 | $-3,505 | $-657 | $-2,828 | $-2,035 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,591 | 49,591 | N/A | 62,898 | 62,898 |
| Common Stock Issued | 516 | 234 | 3 | 433,212 | 435,868 |
| Other Financing Activity | 218,505 | -517 | -300 | -1,144 | -929 |
| Financing Cash Flow | $268,612 | $49,308 | $-297 | $494,966 | $497,837 |
| Exchange Rate Effect | -23 | 45 | 30 | 235 | 98 |
| Beginning Cash Position | 439,195 | 439,195 | 439,195 | 115,551 | 115,551 |
| End Cash Position | 530,194 | 371,884 | 383,122 | 439,195 | 494,416 |
| Net Cash Flow | $90,999 | $-67,311 | $-56,073 | $323,644 | $378,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,747 | -113,159 | -55,149 | -168,729 | -117,035 |
| Capital Expenditure | -3,010 | -1,605 | -657 | -801 | -627 |
| Free Cash Flow | -174,757 | -114,764 | -55,806 | -169,530 | -117,662 |